MEF2C and Stroke: Moreover, the neurological outcome assessed by the mGarcia score, as well as the adhesive removal and grid walking tests were improved in HFD Emx1CreMef2cfl/fl mice up to 28 days following MCAO, suggesting ablation of neuronal Mef2c ameliorates post‐stroke neurological deficits especially.